Thomson-pharma.com is tracked by us since August, 2012. Over the time it has been ranked as high as 289 799 in the world, while most of its traffic comes from China, where it reached as high as 25 476 position. Drugnews.thomson-pharma.com receives less than 1% of its total traffic. It was owned by several entities, from Thomson Reuters Global Resources Unlimited Company to REDACTED FOR PRIVACY of Super Privacy Service LTD c/o Dynadot, it was hosted by Thomson Reuters Ireland Limited, Amazon Technologies Inc. and others. While MarkMonitor Inc. was its first registrar, now it is moved to Dynadot Inc.

Drugnews.thomson-pharma has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Drugnews.thomson-pharma.com is poorly ‘socialized’ in respect to any social network. According to Siteadvisor and Google safe browsing analytics, Drugnews.thomson-pharma.com is quite a safe domain with no visitor reviews.